InMed Pharmaceuticals's total assets for Q3 2026 were C$9.13M, a decrease of -40.54% from the previous quarter. INM total liabilities were C$2.24M for the fiscal quarter, a 1.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.